Public annual accounts

RHUMATOLOGIE COUTELLIER financials

Name: RHUMATOLOGIE COUTELLIER financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for RHUMATOLOGIE COUTELLIER, with comparable measures and links to available source documents.

Company overview

Registry number

0839921218

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for RHUMATOLOGIE COUTELLIER

2025 versus 2024

Operating line: €734,820
EBITDA: €733,246
Total assets: €3,550,472
Equity: €2,390,522

EBITDA margin +99.8% · Equity ratio +67.3%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202530 Sept 2025	€734,820	€733,246	€3,550,472	€2,390,522	-
202430 Sept 2024	€809,692	€808,399	€3,386,483	€2,964,934	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report

Fiscal year

Gross margin

EBITDA

Total assets

Equity

Filing

202530 Sept 2025

€734,820

€733,246

€3,550,472

€2,390,522

202430 Sept 2024

€809,692

€808,399

€3,386,483

€2,964,934